Log in or Sign up for Free to view tailored content for your specialty!
Optics News
Several factors affect VA outcomes after cataract surgery in patients with type 2 diabetes
Although visual prognosis after cataract surgery is usually favorable, factors such as diabetic retinopathy may still limit visual potential in those with type 2 diabetes, according to a study published in the British Journal of Ophthalmology.
Dual contact lens, glasses prescribing ‘represents a significant opportunity’
NEW YORK — Nearly a quarter of more than 2,000 contact lens and spectacle wearers surveyed said they wear both modalities to correct their vision, according to a report from the Contact Lens Institute presented at Vision Expo East.
Log in or Sign up for Free to view tailored content for your specialty!
Haag-Streit launches optometry exam lane in US
Haag-Streit USA has launched the Reliance Optometry Workplace, a cost-effective optometry exam lane solution, the company announced in a press release.
Prism lenses may be the answer for patients with phorias
A phoria is a misalignment or deviation in binocular vision that is often difficult to detect, because the eyes compensate for the difference.
CooperVision launches new myopia control initiative
NEW YORK — CooperVision introduced its “Make Children’s Sight Your Fight” advocacy and education campaign during a press conference at Vision Expo East.
Ortho-K safe, effective, well accepted as myopia correcting technique
Orthokeratology is a viable myopia correcting technique and yielded high satisfaction in adults with low to moderate myopia in China, researchers reported.
Study will evaluate multifocal contact lens, atropine drop therapy for myopia in children
Enrollment is underway for a study evaluating the combined use of multifocal contact lenses and 0.01% atropine eye drops in the management of myopia in children, according to a research protocol published in the Eye & Contact Lens.
Ocumetra launches products to help clinicians manage myopia
NEW YORK — Ocumetra, an optometric data analytics company, announced the January launch of its myopia management products, mEYE Guide and mEYE Gauge, at Vision Expo East.
VIDEO: Orasis shares FDA, clinical study updates
ATLANTA — The FDA has accepted Orasis Pharmaceuticals’ new drug application for CSF-1, and the company shared positive phase 3 trial results, according to Orasis president and chief operating officer Paul Smith at SECO 100.
VIDEO: CSF-1 improved, sustained near visual acuity
ATLANTA — A study of CSF-1 showed an improvement in near visual acuity as well as distance, according to a study presented at SECO 100.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read